Tune Therapeutics

NEWS

Pictured: DNA with methyl marks over DNA sequence

Drug Development

Epigenetic Editing Explodes on the Heels of Gene Editing Success

Ubiquitous potential, possible safety advantages and the recent growth of cell and gene therapy are driving investment in a different type of genetic editing.

March 21, 2024

·

6 min read

·

Heather McKenzie

IN THE PRESS

Business

Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel

April 10, 2023

·

3 min read

Business

Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors

January 17, 2023

·

2 min read

Bio NC

Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases

December 2, 2021

·

4 min read

JOBS